Roche Holding AG
🇨🇭XSWX.ROSwitzerlandNot reported
PriceCHF 375.20-1.20 (-0.32%)
Latest anomalies
Neutral 7 detected in the last 120 days
- High: 2
- Medium: 2
- Low: 3
52-week high: the price is trading close to this level
Volume: a spike above the 20-day average
Daily return: an extreme move up, far outside its trailing 60-day range
Volume: a spike above the 20-day average
52-week high: the price is trading close to this level
Free with a Finzer account.
Profile
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH0012032113
- CUSIP
- Not reported
Company
- Employees
- Not reported
- Headquarters
- Germany
- Website
- Not reported
Market
- Shares outstanding
- 106.7M
- Market cap
- CHF 40.03B
Highlights
- Market cap
- CHF 40.03B
- EPS LTM
- CHF 13.81
- P/E LTM
- 27.17calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 6.3%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CHF 60.77B-5.62%down year on year
- Net income
- CHF 11.03B-24.76%down year on year
- Gross margin
- 72.64%+5.89%up year on year
- Free cash flow
- CHF 11.69B-32.8%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Roche Holding AG is listed on SIX Swiss Exchange (Switzerland) under the ticker RO. Its market capitalisation is CHF 40.03B, from 106.7M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 264.60 and CHF 383.00, and the last close of CHF 375.20 sits 93% of the way up that range. The same company also trades as ROG on Cboe Canada - NEO-L (Market by Order), and as RHO on Frankfurt Stock Exchange.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.